Author:
Rockstroh Jürgen K.,Lennox Jeffrey L.,DeJesus Edwin,Saag Michael S.,Lazzarin Adriano,Wan Hong,Walker Monica L.,Xu Xia,Zhao Jing,Teppler Hedy,DiNubile Mark J.,Rodgers Anthony J.,Nguyen Bach-Yen,Leavitt Randi,Sklar Peter
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Reference10 articles.
1. Sustained antiretroviral efficacy of raltegravir as part of combination antiretroviral therapy in treatment-naive HIV-1 infected patients: 96-week data;J Acquir Immune Defic Syndr,2008
2. Raltegravir with optimized background therapy for resistant HIV-1 infection;N Engl J Med,2008
3. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection;N Engl J Med,2008
4. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial;Lancet,2009
5. Raltegravir versus efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses;J Acquir Immune Defic Syndr,2010
Cited by
153 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献